about
Rates of vaccine evolution show strong effects of latency: implications for varicella zoster virus epidemiologySpecific capture and whole-genome sequencing of viruses from clinical samplesViral population analysis and minority-variant detection using short read next-generation sequencing.Evolution of cocirculating varicella-zoster virus genotypes during a chickenpox outbreak in Guinea-Bissau.Complete Genome Sequence of the Human Herpesvirus 6A Strain AJ from Africa Resembles Strain GS from North America.Recombination of Globally Circulating Varicella-Zoster VirusIn vitro system using human neurons demonstrates that varicella-zoster vaccine virus is impaired for reactivation, but not latency.Next-generation whole genome sequencing identifies the direction of norovirus transmission in linked patients.Mode of virus rescue determines the acquisition of VHS mutations in VP22-negative herpes simplex virus 1.Genome Sequence of Human Herpesvirus 7 Strain UCL-1.Detection of Low Frequency Multi-Drug Resistance and Novel Putative Maribavir Resistance in Immunocompromised Pediatric Patients with CytomegalovirusDeep Sequencing of Distinct Preparations of the Live Attenuated Varicella-Zoster Virus Vaccine Reveals a Conserved Core of Attenuating Single-Nucleotide Polymorphisms.Viral Genome Sequencing Proves Nosocomial Transmission of Fatal Varicella.Deep sequencing of viral genomes provides insight into the evolution and pathogenesis of varicella zoster virus and its vaccine in humans.Acute Retinal Necrosis caused by the zoster vaccine virus.Correction: Specific Capture and Whole-Genome Sequencing of Viruses from Clinical Samples.A spliced latency-associated VZV transcript maps antisense to the viral transactivator gene 61.Comparative genomic, transcriptomic, and proteomic reannotation of human herpesvirus 6.High Viral Diversity and Mixed Infections in Cerebral Spinal Fluid From Cases of Varicella Zoster Virus EncephalitisGoing the distance: optimizing RNA-Seq strategies for transcriptomic analysis of complex viral genomes2018 Colorado Alphaherpesvirus Latency Society SymposiumNuclear-cytoplasmic compartmentalization of the herpes simplex virus 1 infected cell transcriptome is co-ordinated by the viral endoribonuclease vhs and cofactors to facilitate the translation of late proteinsRNA mA modification enzymes shape innate responses to DNA by regulating interferon βMolecular Aspects of Varicella-Zoster Virus LatencyDirect RNA sequencing on nanopore arrays redefines the transcriptional complexity of a viral pathogenHuman cytomegalovirus haplotype reconstruction reveals high diversity due to superinfection and evidence of within-host recombinationWhole genome sequencing of Herpes Simplex Virus 1 directly from human cerebrospinal fluid reveals selective constraints in neurotropic virusesKallikrein-Mediated Cytokeratin 10 Degradation Is Required for Varicella Zoster Virus Propagation in SkinGenetic and phenotypic intrastrain variation in herpes simplex virus type 1 Glasgow strain 17 syn+-derived virusesRecurrent herpes zoster in the Shingles Prevention Study: Are second episodes caused by the same varicella-zoster virus strain?Chromatin dynamics and the transcriptional competence of HSV-1 genomes during lytic infectionsUsing Direct RNA Nanopore Sequencing to Deconvolute Viral TranscriptomesIslands of linkage in an ocean of pervasive recombination reveals two-speed evolution of human cytomegalovirus genomesEvasion of a Human Cytomegalovirus Entry Inhibitor with Potent Cysteine Reactivity Is Concomitant with the Utilization of a Heparan Sulfate Proteoglycan-Independent Route of EntryAnalysis of the reiteration regions (R1 to R5) of varicella-zoster virus
P50
Q28650972-70C97A60-8B55-42FA-B7D1-5EAADFDE41A1Q28742542-F94D6FAB-6BA1-464C-BFCF-A33877898E93Q30426786-A8317A1F-33A9-403C-98B4-20EEB0A9678EQ34594884-43AC1473-0810-4128-8B3C-4121F9F411FFQ35098803-909F2C7D-FE8A-4B47-8C68-F39E27AE9A6EQ35758661-4F298F53-E7B1-4EC4-9752-70806157537EQ36866120-D343DF26-DDB8-46AC-B08F-572CEE38942DQ36987600-9C261E1F-E1D5-40E6-9593-5FFC6B3F71CBQ37123122-2F260DC5-36E5-49E0-9FB5-3D6EAA7F6FA0Q37226036-4F075B40-9F0E-42B4-AA84-74750BFBFE81Q37242897-7D72B098-14B7-40F2-9B49-CE52B30A23D3Q37252950-D4282E62-BF40-4457-AB8F-E3F42865FFAFQ37365076-CF2CA570-656E-4740-824F-1932FCD4CD56Q37532874-F2766E31-123D-4D76-A376-96177689143DQ41919100-8C63A507-75A0-4F8D-A9EF-7CB6982A2D0EQ46430784-59B16DF7-779A-4F1D-AE0E-503F43689BB7Q52643934-745C4A07-39AF-4811-8D09-E13F48E06BD2Q52648412-6B192B98-5004-4654-A84E-D44E14491B54Q57185090-7B01CDCA-E60A-400F-8EF5-BEA0A390071EQ57285035-2666689A-BA67-4CFE-9257-A7671609DDB1Q58566612-F683077A-F60B-4106-97F1-492E859DC1C7Q59350061-32C1D7D1-91F2-4BF2-9DFA-86A7D2DBE860Q59350385-B4215ADE-958F-441E-B08E-BCB970EBD697Q59357897-F5162620-6E5C-4818-BDEB-8801EE4F0C14Q61795989-FB64E849-07E7-4979-93EC-C635B2EF1708Q64092176-3E1E33C6-64C3-4FDF-8599-8AC73DB075D3Q89884908-BF6BCDE4-476C-4CFA-A2AE-32DFC77E1FCDQ90798429-A8C9B504-6CC3-48DB-9FDC-277641622F13Q90984462-7EC608B6-6E43-42F7-AFE5-05A2DEE7CD16Q91077174-68E1D34F-3754-447E-B1AE-7237A9CCD4FDQ91280191-94DA8D89-069C-4024-8037-86690F9C2AECQ91628308-A4BEF9D3-9BBA-4D8D-BB4B-D8C20A4F53E8Q92051210-19BBF69C-2B7B-4EF7-A465-52709C1C9B17Q92668030-DDD5BE34-22FE-4F04-A49F-BEA330EC98D7Q95839247-52462059-EE30-4F0F-A643-AA62CAD7CA2F
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Daniel P Depledge
@en
Daniel P Depledge
@nl
type
label
Daniel P Depledge
@en
Daniel P Depledge
@nl
prefLabel
Daniel P Depledge
@en
Daniel P Depledge
@nl
P31
P496
0000-0002-4292-0599